{{Rsnum
|rsid=9819506
|Chromosome=3
|position=172452314
|Orientation=plus
|GMAF=0.3646
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 49.6 | 44.2 | 6.2
| HCB | 43.4 | 41.2 | 15.4
| JPT | 38.9 | 46.0 | 15.0
| YRI | 19.0 | 52.4 | 28.6
| ASW | 24.6 | 50.9 | 24.6
| CHB | 43.4 | 41.2 | 15.4
| CHD | 43.9 | 42.1 | 14.0
| GIH | 21.8 | 43.6 | 34.7
| LWK | 38.0 | 45.4 | 16.7
| MEX | 50.0 | 44.8 | 5.2
| MKK | 46.4 | 41.2 | 12.4
| TSI | 42.2 | 41.2 | 16.7
| HapMapRevision=28
}}{{PharmGKB
|RSID=rs9819506
|Name_s=
|Gene_s=GHSR
|Feature=
|Evidence=PubMed ID:18698404
|Annotation=A study in 507 middle-aged overweight persons with impaired glucose tolerance participating found an association of this SNP in the promoter region of GHSR with body weight. Participants with rs9819506-AA genotype had the lowest body weight and individuals with rs490683-CC genotype displayed highest weight loss in the whole study population.
|Drugs=
|Drug Classes=
|Diseases=Obesity
|Curation Level=Curated
|PharmGKB Accession ID=PA162191379
}}

{{PMID Auto
|PMID=22411573
|Title=Association of ghrelin receptor promoter polymorphisms with weight loss following Roux-en-Y gastric bypass surgery.
|OA=1
}}

{{GET Evidence
|impact=pharmacogenetic
|qualified_impact=Insufficiently evaluated pharmacogenetic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs9819506
|overall_frequency_n=39
|overall_frequency_d=120
|overall_frequency=0.325
|n_genomes=24
|n_genomes_annotated=0
|n_haplomes=30
|n_articles=1
|n_articles_annotated=0
|in_pharmgkb=Y
|autoscore=1
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}